Butadiene

Butadiene

SCHEMBL2933701

[CH2]/C=C\[CH2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butadiene SCHEMBL28451 1.00
Butadiene SCHEMBL43684 1.00
SCHEMBL43443 0.68
SCHEMBL3931 0.67
SCHEMBL2667 0.63
SCHEMBL1632 0.63
SCHEMBL1631 0.63
SCHEMBL1677666 0.63
SCHEMBL6917167 0.63
SCHEMBL6291935 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024107686-A1 MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE AMGEN INC. (US) 2024-05-23 WO claimed
WO-2024107892-A1 LIQUID WEIGHTING AGENTS FOR OIL-BASED FLUIDS ALBEMARLE CORPORATION (US) 2024-05-23 WO claimed
WO-2023083815-A1 CYCLIC PEPTIDE COMPOUNDS WHICH ARE KISS1R RECEPTOR AGONISTS, AND THERAPEUTIC USES THEREOF INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT (FR) 2023-05-19 WO claimed
CN-115975348-A Resin composition, prepreg, circuit board and printed circuit board 珠海华正新材料有限公司 2023-04-18 CN claimed
US-10011664-B2 Functionalized nitrile rubbers and the production thereof ARLANXEO DEUTSCHLAND GMBH (DE) 2018-07-03 US claimed
US-20170190806-A1 FUNCTIONALISED NITRILE RUBBERS AND THE PRODUCTION THEREOF LANXESS DEUTSCHLAND GMBH (DE) 2017-07-06 US claimed
EP-2484700-B1 Functionalised nitrile rubbers and their manufacture LANXESS DEUTSCHLAND GMBH (DE) 2013-10-09 EP claimed
JP-4267922-B2 2009-05-27 JP claimed
US-20080045522-A1 OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS DOMPE PHA.R.MA S.P.A. (IT) 2008-02-21 US claimed
US-7026510-B2 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them Dompé S.p.A. (IT) 2006-04-11 US claimed
US-20050080067-A1 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells DOMPE S.P A. (IT) 2005-04-14 US claimed
US-20040266870-A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them DOMPÉ FARMACEUTICI S.P.A. (IT) 2004-12-30 US claimed
JP-2004525112-A 2004-08-19 JP claimed
EP-1430020-A1 QUATERNARY AMMONIUM SALTS OF OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Dompé S.P.A. (IT) 2004-06-23 EP claimed
EP-1366018-A1 OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS Dompé S.P.A. (IT) 2003-12-03 EP claimed
WO-2003029187-A1 QUATERNARY AMMONIUM SALTS OF OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMPE S.P.A. (IT) 2003-04-10 WO claimed
WO-2002068377-A1 OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS Dompé S.p.A. (IT) 2002-09-06 WO claimed
EP-0934249-B1 CONFORMATIONALLY RESTRICTED POLYAMINES AND THEIR USE AS ANTINEOPLASTIC AGENTS WISCONSIN ALUMNI RES FOUND (US) 2002-03-27 EP claimed
EP-0937696-A1 Safety-catch linkers Irori (US) 1999-08-25 EP claimed
US-12011425-B2 Hepatitis B antiviral agents ENANTA PHARMACEUTICALS, INC. (US) 2024-06-18 US disclosed
WO-2024107892-A1 LIQUID WEIGHTING AGENTS FOR OIL-BASED FLUIDS ALBEMARLE CORPORATION (US) 2024-05-23 WO disclosed
WO-2024107686-A1 MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE AMGEN INC. (US) 2024-05-23 WO disclosed
EP-4367109-A1 PROCESS FOR PREPARING PERFUMING INTERMEDIATES Firmenich SA (CH) 2024-05-15 EP disclosed
US-11952327-B2 Methods and compositions for terpenoid synthesis UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2024-04-09 US disclosed
US-20240025843-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2024-01-25 US disclosed
EP-3746452-B1 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES US HEALTH (US) 2023-09-13 EP disclosed
US-20230241012-A1 HEPATITIS B ANTIVIRAL AGENTS ENANTA PHARM INC (US) 2023-08-03 US disclosed
EP-3556464-B1 METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND SHINETSU CHEMICAL CO (JP) 2023-08-02 EP disclosed
WO-2023083815-A1 CYCLIC PEPTIDE COMPOUNDS WHICH ARE KISS1R RECEPTOR AGONISTS, AND THERAPEUTIC USES THEREOF INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT (FR) 2023-05-19 WO disclosed
WO-2023083815-A1 CYCLIC PEPTIDE COMPOUNDS WHICH ARE KISS1R RECEPTOR AGONISTS, AND THERAPEUTIC USES THEREOF INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT (FR) 2023-05-19 WO disclosed
CN-115975348-A Resin composition, prepreg, circuit board and printed circuit board 珠海华正新材料有限公司 2023-04-18 CN disclosed
WO-2023036732-A1 PROCESS FOR PREPARING PERFUMING INTERMEDIATES FIRMENICH SA (CH) 2023-03-16 WO disclosed
US-11596611-B2 Hepatitis B antiviral agents ENANTA PHARMACEUTICALS, INC. (US) 2023-03-07 US disclosed
CN-110386863-B Method for producing reduced halide having reduced carbon-carbon unsaturated bond 信越化学工业株式会社 2023-02-28 CN disclosed
CN-109627162-B Process for preparing (7E) -7, 9-decanedioic acid esters 信越化学工业株式会社 2022-11-15 CN disclosed
US-11365211-B2 Stereoselective synthesis and process for the manufacturing of 2′-deoxynucleosides THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2022-06-21 US disclosed
CN-108727165-B Process for producing 2, 4-dienal aldehyde compound and 2, 4-dienal compound 信越化学工业株式会社 2021-11-12 CN disclosed
US-20210283077-A1 HEPATITIS B ANTIVIRAL AGENTS ENANTA PHARM INC (US) 2021-09-16 US disclosed
CN-112824452-A Resin composition, cured product of resin composition, resin sheet, printed wiring board, flexible substrate, and semiconductor device 味之素株式会社 2021-05-21 CN disclosed
US-10952978-B2 Hepatitis B antiviral agents ENANTA PHARMACEUTICALS, INC. (US) 2021-03-23 US disclosed
CN-107304163-B Method for producing aliphatic aldehyde compound having terminal conjugated diene structure and intermediate for use in said method 信越化学工业株式会社 2020-12-25 CN disclosed
EP-3746452-A1 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES The United States of America, as represented by the Secretary, Department of Health and Human Services (US) 2020-12-09 EP disclosed
US-20200361977-A1 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2020-11-19 US disclosed
EP-3675637-A1 HEPATITIS B ANTIVIRAL AGENTS Enanta Pharmaceuticals, Inc. (US) 2020-07-08 EP disclosed
EP-3466917-B1 METHOD FOR PREPARING (7E)- 7,9-DECADIENOATE ESTER SHINETSU CHEMICAL CO (JP) 2020-06-24 EP disclosed
US-10676417-B2 Method for producing reduced halide compound having undergone reduction of carbon-carbon unsaturated bond SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-06-09 US disclosed
EP-3392230-B1 METHOD FOR PRODUCING 2,4-DIENAL ACETAL COMPOUND AND 2,4-DIENAL COMPOUND SHINETSU CHEMICAL CO (JP) 2020-03-04 EP disclosed
CN-110386863-A The method for being prepared with the reduced form halide that carbon-to-carbon unsaturated bond is reduced 信越化学工业株式会社 2019-10-29 CN disclosed
US-20190322607-A1 METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2019-10-24 US disclosed
EP-3556464-A1 METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND Shin-Etsu Chemical Co., Ltd. (JP) 2019-10-23 EP disclosed
US-10442752-B2 Method for preparing (7E)-7, 9-decadienoate ester SHIN-ETSU CHEMICAL CO., LTD. (JP) 2019-10-15 US disclosed
US-20190270700-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS UNIV FLORIDA (US) 2019-09-05 US disclosed
WO-2019152459-A1 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2019-08-08 WO disclosed
US-20190106374-A1 METHOD FOR PREPARING (7E)-7, 9-DECADIENOATE ESTER SHIN-ETSU CHEMICAL CO., LTD. (JP) 2019-04-11 US disclosed
EP-3466917-A1 METHOD FOR PREPARING (7E)- 7,9-DECADIENOATE ESTER Shin-Etsu Chemical Co., Ltd. (JP) 2019-04-10 EP disclosed
WO-2019046271-A1 HEPATITIS B ANTIVIRAL AGENTS ENANTA PHARMACEUTICALS, INC. (US) 2019-03-07 WO disclosed
US-10138179-B2 Method for producing 2,4-dienal acetal compound and 2,4-dienal compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-11-27 US disclosed
EP-3235798-B1 METHOD OF PRODUCING ALIPHATIC ALDEHYDE COMPOUND HAVING TERMINAL CONJUGATED DIENE STRUCTURE AND INTERMEDIATE THEREFOR SHINETSU CHEMICAL CO (JP) 2018-11-07 EP disclosed
US-20180305276-A1 METHOD FOR PRODUCING 2,4-DIENAL ACETAL COMPOUND AND 2,4-DIENAL COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-10-25 US disclosed
EP-3392230-A1 METHOD FOR PRODUCING 2,4-DIENAL ACETAL COMPOUND AND 2,4-DIENAL COMPOUND Shin-Etsu Chemical Co., Ltd. (JP) 2018-10-24 EP disclosed
EP-3214063-B1 TERMINAL CONJUGATED TRIENAL ACETAL COMPOUND AND METHOD FOR PRODUCING TERMINAL CONJUGATED TRIENAL COMPOUND USING THE SAME SHINETSU CHEMICAL CO (JP) 2018-09-12 EP disclosed
US-10040742-B2 Method of producing aliphatic aldehyde compound having terminal conjugated diene structure and intermediate therefor SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-08-07 US disclosed
US-10011664-B2 Functionalized nitrile rubbers and the production thereof ARLANXEO DEUTSCHLAND GMBH (DE) 2018-07-03 US disclosed
WO-2018053322-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2018-03-22 WO disclosed
US-9822050-B2 Terminal conjugated trienal acetal compound and method for producing terminal conjugated trienal compound using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-11-21 US disclosed
EP-3235798-A1 METHOD OF PRODUCING ALIPHATIC ALDEHYDE COMPOUND HAVING TERMINAL CONJUGATED DIENE STRUCTURE AND INTERMEDIATE THEREFOR Shin-Etsu Chemical Co., Ltd. (JP) 2017-10-25 EP disclosed
US-20170297987-A1 METHOD OF PRODUCING ALIPHATIC ALDEHYDE COMPOUND HAVING TERMINAL CONJUGATED DIENE STRUCTURE AND INTERMEDIATE THEREFOR SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-10-19 US disclosed
US-20170253548-A1 Terminal Conjugated Trienal Acetal Compound and Method for Producing Terminal Conjugated Trienal Compound Using the Same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-09-07 US disclosed
EP-3214063-A1 TERMINAL CONJUGATED TRIENAL ACETAL COMPOUND AND METHOD FOR PRODUCING TERMINAL CONJUGATED TRIENAL COMPOUND USING THE SAME Shin-Etsu Chemical Co., Ltd. (JP) 2017-09-06 EP disclosed
US-20170190806-A1 FUNCTIONALISED NITRILE RUBBERS AND THE PRODUCTION THEREOF LANXESS DEUTSCHLAND GMBH (DE) 2017-07-06 US disclosed
US-9570688-B2 Semiconductor materials prepared from bridged bithiazole copolymers BASF SE (DE) 2017-02-14 US disclosed
EP-2686325-B1 MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2016-12-14 EP disclosed
US-9493402-B2 Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells DOMPÉ FARMACEUTICI S.P.A. (IT) 2016-11-15 US disclosed
EP-2601236-B1 SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS BASF SE (DE) 2016-11-02 EP disclosed
US-20160145247-A1 Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof NOVARTIS AG (CH) 2016-05-26 US disclosed
EP-3022182-A1 AMINOMETHYL-BIARYL DERIVATIVES AS COMPLEMENT FACTOR D INHIBITORS AND USES THEREOF Novartis AG (CH) 2016-05-25 EP disclosed
WO-2016014954-A1 TANDEM Z-SELECTIVE METATHESIS / DIHYDROXYLATION CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2016-01-28 WO disclosed
US-20150162546-A1 SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COMPOLYERS BASF SE (DE) 2015-06-11 US disclosed
WO-2015009977-A1 AMINOMETHYL-BIARYL DERIVATIVES AS COMPLEMENT FACTOR D INHIBITORS AND USES THEREOF NOVARTIS AG (CH) 2015-01-22 WO disclosed
EP-2686325-A1 MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2014-01-22 EP disclosed
US-20130144065-A1 SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS POLYERA CORPORATION (US) 2013-06-06 US disclosed
US-20130079514-A1 \"OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS\ Dompé S.p.A. (IT) 2013-03-28 US disclosed
US-8288368-B2 inhibitors of the C5a induced chemotaxis; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, rheumatoid arthritis and in the prevention and the treatment of injury caused by ischemia and reperfusion DOMPÉ PHA.R.MA S.P.A. (IT) 2012-10-16 US disclosed
WO-2012125613-A1 MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-09-20 WO disclosed
EP-2229377-A1 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS Wyeth LLC (US) 2010-09-22 EP disclosed
US-20100022559-A1 BISOXIMES AS FUNGICIDES BAYER CROPSCIENCE AG (DE) 2010-01-28 US disclosed
WO-2009076602-A1 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS WYETH (US) 2009-06-18 WO disclosed
WO-2009009597-A1 WATER SOLUBLE OLEFIN METATHESIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-01-15 WO disclosed
US-20080045522-A1 OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS DOMPE PHA.R.MA S.P.A. (IT) 2008-02-21 US disclosed
US-7026510-B2 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them Dompé S.p.A. (IT) 2006-04-11 US disclosed
US-20050080067-A1 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells DOMPE S.P A. (IT) 2005-04-14 US disclosed
US-20040266870-A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them DOMPÉ FARMACEUTICI S.P.A. (IT) 2004-12-30 US disclosed
US-6794530-B1 1,4-ADDITION OF MONOHYDRIC OR POLYHYDRIC ALCOHOLS TO ALPHA , BETA -UNSATURATED NITRILES BASF AKTIENGESELLSCHAFT (DE) 2004-09-21 US disclosed
EP-1430020-A1 QUATERNARY AMMONIUM SALTS OF OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Dompé S.P.A. (IT) 2004-06-23 EP disclosed
EP-1366018-A1 OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS Dompé S.P.A. (IT) 2003-12-03 EP disclosed
WO-2003029187-A1 QUATERNARY AMMONIUM SALTS OF OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMPE S.P.A. (IT) 2003-04-10 WO disclosed
EP-0934925-B1 Process for the preparation of beta-alkoxy nitriles BASF AG (DE) 2002-09-25 EP disclosed
WO-2002068377-A1 OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS Dompé S.p.A. (IT) 2002-09-06 WO disclosed
EP-0937696-A1 Safety-catch linkers Irori (US) 1999-08-25 EP disclosed
EP-0934925-A1 Process for the preparation of beta-alkoxy nitriles BASF AKTIENGESELLSCHAFT (DE) 1999-08-11 EP disclosed
US-5443820-A Esters and amides of aminomethylenecyanoacetic acid a cosmetic preparation containing the same as a sunscreen agent and a method for protecting human skin using the same BASF AKTIENGESELLSCHAFT (DE) 1995-08-22 US disclosed
EP-0150461-B1 SULFUR CONTAINING 6-KETOPROSTAGLANDINES MERCK PATENT GmbH (DE) 1988-03-30 EP disclosed
US-4680288-A Sulfur-containing 6-ketoprostaglandins MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-07-14 US disclosed
EP-0150461-A2 Sulfur containing 6-Ketoprostaglandines MERCK PATENT GmbH (DE) 1985-08-07 EP disclosed
EP-0084775-A1 13-Thia-prostacyclines MERCK PATENT GmbH (DE) 1983-08-03 EP disclosed
EP-0084775-A1 13-Thia-prostacyclines MERCK PATENT GmbH (DE) 1983-08-03 EP disclosed